Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: A study by the Hellenic Cooperative Oncology Group

Journal of Clinical Oncology

Volumn 22, Issue 11, 2004, Pages 2150-2154

  Bamias, Aristotle ^a   Deliveliotis, Ch ^a   Fountzilas, G ^a   Gika, D ^a   Anagnostopoulos, A ^a   Zorzou, M P ^a   Kastritis, E ^a   Constantinides, C ^a   Kosmidis, P ^a   Dimopoulos, M A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; FEVER; HUMAN; METASTASIS; NEUTROPENIA; PRIORITY JOURNAL; SIDE EFFECT; URINARY TRACT CARCINOMA; ADULT; AGED; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEASIBILITY STUDY; FEMALE; GREECE; KIDNEY PELVIS; KIDNEY TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; SURVIVAL RATE; URETER TUMOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; GREECE; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; SURVIVAL RATE; URETERAL NEOPLASMS;

EID: 2942696475     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.09.043     Document Type: Article

References (37)

1. Bloom NA, Vidone RA, Lytton B: Primary carcinoma of the ureter: A report of 102 new cases. J Urol 103:590-598, 1970
2. Guinan P, Vogelzang NJ, Randazzo R, et al: Renal pelvic cancer: A review of 611 patients treated in Illinois 1975-1985. Cancer Incidence and End Results Committee. Urology 40:393-399, 1992
3. Hall C, Womack S, Sagalowsky AI, et al: Prognostic factors, recurrence, and survival in transitional cell carcinoma of the urinary tract: A 30-year experience in 252 patients. Urology 52: 594-601, 1998
4. Cozad SC, Smalley SR, Austenfeld M, et al: Transitional cell carcinoma of the renal pelvis or ureter: Patterns of failure. Urology 46:796-800, 1995
5. Kirkali Z, Tuzel E: Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47:155-169, 2003
6. Lerner SE, Blute ML, Richardson RL, et al: Platinum based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract. Mayo Clin Proc 71:945-950, 1996
7. Roth BJ, Dreicer R, Einhorn LH, et al: Significant activity of Paclitaxel in advanced transitional-cell carcinoma of the urothelium: A phase II trial of the Eastern Coopertaive Oncology Group. J Clin Oncol 12:2264-2270, 1994
8. McCaffrey JA, Hilton S, Mazumdar M, et al: Phase II trial of Docetaxel in patients with advanced or metastatic transitional-cell carcinoma. J Clin Oncol 15:1853-1857, 1997
9. Mottet-Auselo N, Bons-Rosset F, Costa P, et al: Carboplatin and urothelial tumors. Oncology 50:28-36, 1993 (suppl 2)
10. Vaughn DJ, Malkowicz SB, Zoltick B, et al: Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: An active and tolerable outpatients regimen. J Clin Oncol 16:255-260, 1998
11. Redman BG, Smith DC, Flaherty L, et al: Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma. J Clin Oncol 16:1844-1848, 1998
12. Kaplan EL, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 53:457-481, 1958
13. Sternberg C, Yakoda A, Scher HI, et al: M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 139:461-469, 1988
14. Loehler PJ, Einhorn LH, Elson PJ, et al: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma. J Clin Oncol 10:1066-1073, 1992
15. Dimopoulos MA, Bakoyiannis C, Georgoulias V, et al: Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group. Ann Oncol 10:1385-1388, 1999
16. Bajorin DF, Dodd PM, Mazumdar M, et al: Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of treatment. J Clin Oncol 17:3173-3181, 1999
17. Skinner DG, Daniels JR, Russell CA, et al: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial. J Urol 145:459-167, 1991
18. Stockle M, Meyenburg W, Wellek S, et al: Advanced bladder cancer (stages pTeb, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 cycles of adjuvant chemotherapy. J Urol 148:302-306, 1992
19. Studer UE, Bacchi M, Biederman C, et al: Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: Results of a prospective randomized trial. J Urol 152:81-84, 1994
20. Freiha F, Reese J, Torti FM: A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155:495-499, 1996
21. Bono AV, Benvenuti C, Reali L, et al: Adjuvant chemotherapy in locally advanced bladder cancer: Final analysis of a controlled multicentre study. Acta Urol Ital 11:5-8, 1997
22. Dimopoulos MA, Moulopoulos LA: Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder. J Clin Oncol 16:1601-1612, 1998
23. de Wit R: Overview of bladder cancer trials in the European Organization for Research and Treatment. Cancer 97:2120-2126, 2003
24. Sharma P, Bajorin D: Controversies in neoadjuvant and adjuvant chemotherapy for muscle-invasive urothelial cancer and clinical research initiatives in locally advanced disease. In: 2003 ASCO Educational Book, Alexandria, VA, American Society of Clinical Oncology, pp: 478-487
25. Morioka M, Jo Y, Furukawa Y, et al: Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract. Int J Urol 8:366-373, 2001
26. Mufti GR, Gove JRW, Badenoch DF, et al: Transitional cell carcinoma of the renal pelvis and ureter. Br J Urol 63:135-140, 1989
27. Masuda M, Tanao Y, Iki M, et al: Apoptosis in transitional cell carcinoma of the renal pelvis and ureter: Association with proliferative activity, bcl-2 expression and prognosis. J Urol 158:750-753, 1997
28. Rey A, Lara PC, Redondo E. et al: Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Cancer 79:2178-2185, 1997
29. Racioppi M, D'Adessi A, Alcini A, et al: Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumors. Br J Urol 80:707-711, 1997
30. Corrado F, Ferri C, Mannini D, et al: Transitional cell carcinoma of the upper urinary tract: Evaluation of prognostic factors by histopathology and flow cytometric analysis. J Urol 145: 1159-1163, 1991
31. von der Maase H, Hansen SW, Roberts JT, et al: Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study. J Clin Oncol 18:3068-3077, 2000
32. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis. Lancet 361:1927-1934, 2003
33. Grossman HB, Natale RB, Tangen CM, et al: Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859-866, 2003
34. Maulard-Durdux C, Dufour B, Hennequin C, et al: Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: No impact on survival? J Urol 155:115-117, 1996
35. Hall C, Womack JS, Roehrborn CG, et al: Advanced transitional cell carcinoma of the upper urinary tract: Patterns of failure, survival and impact of postoperative adjuvant radiotherapy. J Urol 160:703-706, 1998
36. Babaian RJ. Johnson DE, Chan RC: Combination nephrouterectomyand postoperative radiotherapy for infiltrative ureteral carcinoma. Int J Radiat Oncol Biol Phys 6:1229, 1980
37. Brookland RK, Richter MP: The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter. J Urol 133:952, 1985